Stroke is one of the leading causes of morbidity and mortality till date was neglected because of the long-term care and multi-disciplinary approach. But with introduction of a stroke code with mobile facilities for thrombolysis like STEMI improved the outlook and outcome of this serius vascular disease. By 2015 world over five major trials like MR Clean to REVASCAT trials showed the benefit of IV thrombolysis followed by mechanical thrombectomy with stent retrievers like solitaire, TREVA devices was superior to IV thrombolysis alone.
But the recent issue of JAMA neurology discuss there is no added advantage of IV thrombolysis before mechanical thrombectomy if the stroke code has the immediate facility of providing mechanical thrombectomy alone because of less chances of hemorrhage creates narrowing in of a costly procedure to prompt mechanical revascularization. Is it a false hope or…
